Search results
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 1 day agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares ...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 7 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 4 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
How To Earn $500 A Month From Pfizer Stock
Benzinga via AOL· 7 days agoShares of Pfizer Inc. (NYSE:PFE) closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 6 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream....
EU regulator backs use of Pfizer's gene therapy for rare bleeding disorder
Reuters via AOL· 7 days agoThe regulator has recommended granting a 'conditional marketing authorization,' which is for the...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 3 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
Pfizer: New Cancer Drugs Could Breathe New Life Into Struggling Pharma Behemoth
Investing.com· 3 days agoPharmaceutical stocks, once pandemic favorites, have faced significant corrections. Despite broader...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 7 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...